Daniel Lozano Selected Research

parathyroid hormone-related protein (107-111)

7/2012	Osteostatin-loaded onto mesoporous ceramics improves the early phase of bone regeneration in a rabbit osteopenia model.
10/2011	Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Lozano Research Topics

Disease

6	Neoplasms (Cancer) 03/2021 - 08/2017
4	Infections 12/2021 - 01/2020
3	Osteoporosis 01/2021 - 07/2012
3	Burns 07/2014 - 03/2006
3	Metabolic Bone Diseases (Osteopenia) 07/2012 - 05/2009
3	Wounds and Injuries (Trauma) 10/2011 - 08/2004
2	Chagas Disease (American Trypanosomiasis) 12/2021 - 01/2021
2	Osteosarcoma (Osteogenic Sarcoma) 04/2020 - 01/2018
2	Bone Diseases (Bone Disease) 01/2019 - 04/2010
1	Bacterial Infections (Bacterial Infection) 11/2021
1	Parasitemia 01/2021
1	Disease Progression 01/2021
1	Leishmaniasis 01/2021
1	Coinfection 01/2021
1	Bone Neoplasms (Bone Cancer) 01/2018
1	Pulmonary Tuberculosis 06/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2015
1	Multiple Organ Failure (MODS) 06/2015
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 06/2015
1	Bone Fractures (Bone Fracture) 01/2015
1	Inflammation (Inflammations) 04/2013
1	Bone Resorption 04/2012
1	Hypoxia (Hypoxemia) 01/2012
1	Hyperglycemia 05/2011
1	Body Weight (Weight, Body) 05/2011
1	Hypercholesterolemia 05/2011
1	Hypertriglyceridemia 05/2011

Drug/Important Bio-Agent (IBA)

6	Silicon Dioxide (Silica)FDA LinkGeneric 11/2021 - 08/2017
5	Pharmaceutical PreparationsIBA 03/2021 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2020 - 01/2018
2	parathyroid hormone-related protein (107-111)IBA 07/2012 - 10/2011
2	Parathyroid Hormone-Related ProteinIBA 04/2010 - 05/2009
1	Biological ProductsIBA 03/2021
1	CytokinesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Biocompatible Materials (Biomaterials)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	LectinsIBA 01/2018
1	Plant LectinsIBA 01/2018
1	AcidsIBA 01/2018
1	AcetalsIBA 01/2018
1	carbopol 940 (sodium polyacrylate)IBA 01/2018
1	LigandsIBA 01/2018
1	Concanavalin AIBA 01/2018
1	Sialic AcidsIBA 01/2018
1	Polysaccharides (Glycans)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2017
1	Differentiation AntigensIBA 04/2013
1	CateninsIBA 04/2013
1	Methylprednisolone FDA LinkGeneric 07/2012
1	parathyroid hormone-related protein (107-139)IBA 04/2012
1	Oxygen (Dioxygen)IBA 01/2012
1	Exenatide (Byetta)FDA Link 05/2011
1	Insulin (Novolin)FDA Link 05/2011
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2011
1	Peptides (Polypeptides)IBA 04/2010
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 05/2007
1	Thrombin FDA Link 05/2007
1	Explosive Agents (Explosives)IBA 03/2006

Therapy/Procedure

7	Therapeutics 12/2021 - 04/2010
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2015
1	Continuity of Patient Care 07/2014
1	Skin Transplantation (Skin Grafting) 03/2006
1	Artificial Skin 08/2004